Journal of Experimental & Clinical Cancer Research

Scientists at Tohoku University have discovered a novel approach that improves the efficacy of immune checkpoint blockade - a novel form of cancer treatment utilizing immune checkpoint inhibitors - and minimizes the associated side effects. Using immune checkpoint blockades to target tumor-positive lymph nodes, they generated a robust anti-tumor response against both local and systemic metastases.

Researchers from Korea reveal the key protein involved in the development of aggressive prostate cancer